Searched over 200M research papers for "smokers lungs"
10 papers analyzed
These studies suggest that smoking tobacco significantly harms lung health, increasing the risk of various lung diseases, while quitting smoking or switching to electronic cigarettes can improve lung function and reduce respiratory symptoms.
20 papers analyzed
Smoking significantly elevates the risk of several severe respiratory diseases. Among adult smokers, the risk of lung cancer is dramatically higher, with a risk ratio (RR) of 10.92, chronic obstructive pulmonary disease (COPD) with an RR of 4.01, and asthma with an RR of 1.61. These findings underscore the severe impact of smoking on respiratory health.
Exposure to second-hand smoke also poses significant health risks. Non-smokers exposed to passive smoke have an increased risk of lung cancer, while children exposed to passive smoke are more likely to suffer from asthma, wheeze, lower respiratory infections, and reduced lung function.
Quitting smoking leads to notable improvements in lung function and respiratory symptoms. In a study involving smokers who switched to electronic cigarettes (ECs), those who completely abstained from smoking showed significant improvements in their forced expiratory flow (FEF25-75%) and a reduction in symptoms like cough and shortness of breath. Another study found that smokers who quit experienced an initial improvement in forced expiratory volume in one second (FEV1) and a slower rate of decline in lung function compared to those who continued smoking.
The long-term benefits of smoking cessation are substantial. Sustained quitters show a rate of lung function decline comparable to never-smokers, highlighting the potential for significant recovery even after prolonged smoking.
Smoking is linked to a range of histologic changes in the lungs, including emphysema, respiratory bronchiolitis, and desquamative interstitial pneumonia. These conditions are characterized by inflammation and fibrosis of the lung tissue, which can lead to progressive lung damage .
Young smokers exhibit specific pathologic changes in their peripheral airways, such as respiratory bronchiolitis and increased inflammatory cells, which are rarely seen in non-smokers. These changes are considered precursors to more severe conditions like centriacinar emphysema.
Not all smokers develop chronic lung diseases, indicating that individual susceptibility plays a crucial role. Comparative studies of pathogenic mechanisms have shown that smoking can lead to either emphysema or pulmonary fibrosis, depending on various biological factors.
In smokers with COPD, the progression of emphysema and air trapping can be quantified using CT scans. Over a five-year period, significant increases in these conditions were observed, with changes in FEV1 accounting for a portion of the progression.
Many smokers who do not meet the clinical criteria for COPD still experience significant respiratory symptoms. These individuals have higher rates of respiratory exacerbations, activity limitations, and evidence of airway disease, despite having preserved pulmonary function.
Lower respiratory illnesses (LRIs) significantly affect lung function in current smokers but not in ex-smokers. Smokers who experience frequent LRIs show a greater decline in FEV1, highlighting the interactive effect of smoking and respiratory illnesses on lung health.
Smoking has a profound and multifaceted impact on lung health, increasing the risk of severe respiratory diseases, causing significant histologic and pathologic changes, and leading to long-term declines in lung function. However, smoking cessation can lead to substantial improvements in lung function and a reduction in respiratory symptoms, emphasizing the critical importance of quitting smoking for lung health.
Most relevant research papers on this topic